NVP-AUY922:: A novel small molecule HSP90 inhibitor with potent in vivo antitumor efficacy

被引：0

作者：

Jensen, Michael Rugaard ^{[1
]}

Schoepfer, Joseph ^{[1
]}

Radimersky, Thomas ^{[1
]}

Massey, Andrew ^{[2
]}

Brueggen, Josef ^{[1
]}

Schweitzer, Alain ^{[3
]}

Pfaar, Ulrike ^{[3
]}

Ruetz, Stephan ^{[1
]}

Guy, Chantal ^{[4
]}

Buckler, Alan ^{[4
]}

Schnell, Christian ^{[1
]}

Cozens, Robert ^{[1
]}

Brough, Paul ^{[2
]}

Drysdale, Martin ^{[2
]}

Quadt, Cornelia ^{[3
]}

Garcia-Echeverria, Carlos ^{[1
]}

Chene, Patrick ^{[1
]}

机构：

[1] Novartis Inst BioMed Res, Basel, Switzerland

[2] Vernalis Ltd, Cambridge, England

[3] Novartis Pharma AG, Basel, Switzerland

[4] Novartis Inst BioMed Res, Cambridge, England

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3521S / 3521S

页数：1

共 50 条

[1] NVP-AUY922:: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
Jensen, Michael Rugaard
Schoepfer, Joseph
Radimerski, Thomas
Massey, Andrew
Guy, Chantale T.
Brueggen, Josef
Quadt, Cornelia
Buckler, Alan
Cozens, Robert
Drysdale, Martin J.
Garcia-Echeverria, Carlos
Chene, Patrick
BREAST CANCER RESEARCH, 2008, 10 (02)
[2] NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
Michael Rugaard Jensen
Joseph Schoepfer
Thomas Radimerski
Andrew Massey
Chantale T Guy
Josef Brueggen
Cornelia Quadt
Alan Buckler
Robert Cozens
Martin J Drysdale
Carlos Garcia-Echeverria
Patrick Chène
Breast Cancer Research, 10
[3] Novel Hsp90 Inhibitor NVP-AUY922 Radiosensitizes Prostate Cancer Cells
Gandhi, N.
Wild, A. T.
Aziz, K.
Chettiar, S.
Gajula, R.
Zeng, J.
Herman, J.
Deweese, T. L.
Hales, R.
Tran, P. T.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S178 - S178
[4] NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo
Lian, Jianpo
Lin, Dengqiang
Xie, Xing
Xu, Yunze
Xu, Lieyu
Meng, Li
Zhu, Yu
ONCOTARGETS AND THERAPY, 2017, 10 : 2219 - 2226
[5] Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Gandhi, Nishant
Wild, Aaron T.
Chettiar, Sivarajan T.
Aziz, Khaled
Kato, Yoshinori
Gajula, Rajendra P.
Williams, Russell D.
Cades, Jessica A.
Annadanam, Anvesh
Song, Danny
Zhang, Yonggang
Hales, Russell K.
Herman, Joseph M.
Armour, Elwood
DeWeese, Theodore L.
Schaeffer, Edward M.
Tran, Phuoc T.
CANCER BIOLOGY & THERAPY, 2013, 14 (04) : 347 - 356
[6] Antitumor Effect of Novel HSP90 Inhibitor NVP-AUY922 against Oral Squamous Cell Carcinoma
Okui, Tatsuo
Shimo, Tsuyoshi
Hassan, Nur Mohammad Monsur
Fukazawa, Takuya
Kurio, Naito
Takaoka, Munenori
Naomoto, Yoshio
Sasaki, Akira
ANTICANCER RESEARCH, 2011, 31 (04) : 1197 - 1204
[7] The novel HSP90 inhibitor NVP-AUY922 demonstrates activity in rhabdomyosarcoma cell lines
Slater, O.
Renshaw, J.
Workman, P.
Pritchard-Jones, K.
EJC SUPPLEMENTS, 2009, 7 (02): : 593 - 593
[8] Novel Hsp90 inhibitor NVP-AUY922 sensitizes human tumor xenografts to radiation
Kuger, S.
Elsner, I
Katzer, A.
Flentje, M.
Djuzenova, C. S.
STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 117 - 117
[9] Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma
Gaspar, Nathalie
Sharp, Swee Y.
Eccles, Suzanne A.
Gowan, Sharon
Popov, Sergey
Jones, Chris
Pearson, Andrew
Vassal, Gilles
Workman, Paul
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1219 - 1233
[10] Preclinical evaluation of the novel, potent diarylisoxazole resorcinol HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastomas
Gaspar, Nathalie
Sharp, Swee
Eccles, Sue
Valenti, Melanie
Patterson, Lisa
Gowan, Sharon
Jones, Chris
Vassal, Gilles
Pearson, Andrew
Workman, Paul
NEURO-ONCOLOGY, 2008, 10 (03) : 513 - 513

← 1 2 3 4 5 →